Search results
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Zacks via Yahoo Finance· 4 hours agoJohnson possesses a Zacks Rank of #3 (Hold). Digging into valuation, Johnson & Johnson currently has...
3 Magnificent Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 5 days agoHowever, the company's wireless business is strong. Most importantly, Verizon should be able to give...
These Small-Cap Stocks Pay Juicier Dividends Than Many Big Names
Barrons.com· 10 hours agoAnother thing to consider for small-cap dividend payers is that the sector concentrations can vary...
Estimating The Intrinsic Value Of Johnson Controls International plc (NYSE:JCI)
Simply Wall St. via Yahoo Finance· 13 hours agoToday, we will estimate the stock's intrinsic value by projecting its future cash flows and then...
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
Zacks via Yahoo Finance· 12 hours agoHIV sales are projected to grow in the high single-digit to low double-digit range in 2024. Zacks...
The Potential Rise in the Price of Johnson & Johnson
Knox Daily· 2 days agoJohnson & Johnson shares valued at $9,281,969 were divested by the EVP, WW Chair, Pharmaceuticals at a price of $156.27 per share. As ...
Johnson & Johnson hit with hefty verdict in baby powder case - The Boston Globe
The Boston Globe· 1 day agoJohnson & Johnson was ordered by an Oregon jury to pay $260 million to a woman who blamed her cancer...
California State Teachers Retirement System Acquires 48,300 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoCalifornia State Teachers Retirement System lifted its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.3% in the 4th quarter, according to the ...
Insider Selling: President & CEO Robert Johnson Sells Shares of Silicon Laboratories Inc (SLAB)
GuruFocus.com via Yahoo Finance· 1 day agoThe transaction was executed at an average price of $123.8 per share, leading to a total value of...
Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained...
Benzinga via AOL· 2 days agoMonday, Johnson & Johnson (NYSE:JNJ) announced longer-term data from Phase 1/2 MajesTEC-1 study of...